Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma. Reply

Research output: Contribution to journal › Letter › peer-review

4 Scopus citations

Original language	English
Pages (from-to)	957
Number of pages	1
Journal	New England Journal of Medicine
Volume	385
Issue number	10
DOIs	https://doi.org/10.1056/NEJMc2110897
State	Published - 2 Sep 2021

Access to Document

@article{69266d2a564c4be58737dfe91797739c,

title = "Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma. Reply",

author = "Bajorin, \{Dean F.\} and Sandra Collette and Galsky, \{Matthew D.\}",

year = "2021",

month = sep,

day = "2",

doi = "10.1056/NEJMc2110897",

language = "English",

volume = "385",

pages = "957",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "10",

}

TY - JOUR

T1 - Adjuvant Nivolumab in Muscle-Invasive Urothelial Carcinoma. Reply

AU - Bajorin, Dean F.

AU - Collette, Sandra

AU - Galsky, Matthew D.

PY - 2021/9/2

Y1 - 2021/9/2

UR - https://www.scopus.com/pages/publications/85115283135

U2 - 10.1056/NEJMc2110897

DO - 10.1056/NEJMc2110897

M3 - Letter

C2 - 34469656

AN - SCOPUS:85115283135

SN - 0028-4793

VL - 385

SP - 957

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 10

ER -